125 related articles for article (PubMed ID: 3724597)
21. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
22. In vivo epiluminescence microscopy of pigmented skin lesions. II. Diagnosis of small pigmented skin lesions and early detection of malignant melanoma.
Steiner A; Pehamberger H; Wolff K
J Am Acad Dermatol; 1987 Oct; 17(4):584-91. PubMed ID: 3668003
[TBL] [Abstract][Full Text] [Related]
23. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment.
Urist MM; Balch CM; Soong SJ; Milton GW; Shaw HM; McGovern VJ; Murad TM; McCarthy WH; Maddox WA
Ann Surg; 1984 Dec; 200(6):769-75. PubMed ID: 6508408
[TBL] [Abstract][Full Text] [Related]
24. Cutaneous malignant melanoma in Australia, 1989.
Jelfs PL; Giles G; Shugg D; Coates M; Durling G; Fitzgerald P; Ring I
Med J Aust; 1994 Aug; 161(3):182-7. PubMed ID: 8035720
[TBL] [Abstract][Full Text] [Related]
25. Role of In Vivo Reflectance Confocal Microscopy in the Analysis of Melanocytic Lesions.
Serban ED; Farnetani F; Pellacani G; Constantin MM
Acta Dermatovenerol Croat; 2018 Apr; 26(1):64-67. PubMed ID: 29782304
[TBL] [Abstract][Full Text] [Related]
26. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.
Minini R; Rohrmann S; Braun R; Korol D; Dehler S
Melanoma Res; 2017 Apr; 27(2):145-151. PubMed ID: 27926588
[TBL] [Abstract][Full Text] [Related]
27. The classification of primary cutaneous malignant melanoma. A prospective study of 60 cases using Clark's classification.
Larsen TE
Acta Pathol Microbiol Scand A; 1978 Sep; 86A(5):451-9. PubMed ID: 716906
[TBL] [Abstract][Full Text] [Related]
28. Estimated risk of progression of lentigo maligna to lentigo maligna melanoma.
Menzies SW; Liyanarachchi S; Coates E; Smith A; Cooke-Yarborough C; Lo S; Armstrong B; Scolyer RA; Guitera P
Melanoma Res; 2020 Apr; 30(2):193-197. PubMed ID: 31095041
[TBL] [Abstract][Full Text] [Related]
29. Survival from preinvasive and invasive malignant melanoma in Western Australia.
Lemish WM; Heenan PJ; Holman CD; Armstrong BK
Cancer; 1983 Aug; 52(3):580-5. PubMed ID: 6861096
[TBL] [Abstract][Full Text] [Related]
30. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathologic features and behavior of cutaneous eyelid melanoma.
Vaziri M; Buffam FV; Martinka M; Oryschak A; Dhaliwal H; White VA
Ophthalmology; 2002 May; 109(5):901-8. PubMed ID: 11986095
[TBL] [Abstract][Full Text] [Related]
32. Histological type and biological behavior of primary cutaneous malignant melanoma. 1. An analysis of 1916 cases.
Søndergaard K
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):315-31. PubMed ID: 6415909
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of exon 15 BRAF mutations in primary melanoma of the superficial spreading, nodular, acral, and lentigo maligna subtypes.
Lang J; MacKie RM
J Invest Dermatol; 2005 Sep; 125(3):575-9. PubMed ID: 16117801
[TBL] [Abstract][Full Text] [Related]
34. Lentigo maligna and malignant melanoma.
Jackson R; Williamson GS; Beattie WG
Can Med Assoc J; 1966 Oct; 95(17):846-51. PubMed ID: 5922502
[TBL] [Abstract][Full Text] [Related]
35. [Survival analysis in patients with cutaneous malignant melanoma].
Radović-Kovacević V; Pekmezović T; Adanja B; Jarebinski M; Marinković J; Tomin R
Srp Arh Celok Lek; 1997; 125(5-6):132-7. PubMed ID: 9265233
[TBL] [Abstract][Full Text] [Related]
36. Biological behavior and natural course of acral malignant melanoma. Clinical and histologic features and prognosis of palmoplantar, subungual, and other acral malignant melanomas.
Jimbow K; Takahashi H; Miura S; Ikeda S; Kukita A
Am J Dermatopathol; 1984; 6 Suppl():43-53. PubMed ID: 6528942
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous malignant melanoma in Norway: experiences from the Norwegian Melanoma Project.
Selvaag E; Loeb M; Eeg Larsen T; Thune P
Melanoma Res; 1999 Feb; 9(1):92-5. PubMed ID: 10338339
[TBL] [Abstract][Full Text] [Related]
38. The contribution of nodular subtype to melanoma mortality in the United States, 1978 to 2007.
Shaikh WR; Xiong M; Weinstock MA
Arch Dermatol; 2012 Jan; 148(1):30-6. PubMed ID: 21931016
[TBL] [Abstract][Full Text] [Related]
39. Clinically amelanotic or hypomelanotic melanoma: Anatomic distribution, risk factors, and survival.
Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
J Am Acad Dermatol; 2018 Oct; 79(4):645-651.e4. PubMed ID: 30241625
[TBL] [Abstract][Full Text] [Related]
40. Nodular melanoma is less likely than superficial spreading melanoma to be histologically associated with a naevus.
Pan Y; Adler NR; Wolfe R; McLean CA; Kelly JW
Med J Aust; 2017 Oct; 207(8):333-338. PubMed ID: 29020904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
